Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (301290) — Capital Reinvestment Ratio
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (301290) has a Capital Reinvestment Ratio of 0.92x as of December 2024, meaning it reinvests 1% of its operating cash flow (CN¥126.49 Million) in capital expenditures (CN¥115.96 Million). Check Jiangsu Canopus Wisdom Medical Technolog tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A Capital Reinvestment Ratio (2020–2024)
This chart tracks Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A's Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see how efficiently does Jiangsu Canopus Wisdom Medical Technolog generate cash.
Annual Capital Reinvestment Ratio for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (2020–2024)
Year-by-year Capital Reinvestment Ratio for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A from 2020 to 2024. See Jiangsu Canopus Wisdom Medical Technolog free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.92x | CN¥126.49 Million | CN¥115.96 Million | ▲ +34.2% |
| 2023 | 0.68x | CN¥163.13 Million | CN¥111.46 Million | ▼ -13.0% |
| 2022 | 0.79x | CN¥94.63 Million | CN¥74.35 Million | ▲ +34.2% |
| 2021 | 0.59x | CN¥163.45 Million | CN¥95.67 Million | ▲ +162.6% |
| 2020 | 0.22x | CN¥114.07 Million | CN¥25.43 Million | — |